These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23740131)

  • 1. Correction of hyperphosphatemia suppresses cardiac remodeling in uremic rats.
    Yamazaki-Nakazawa A; Mizobuchi M; Ogata H; Kumata C; Kondo F; Ono N; Koiwa F; Uda S; Kinugasa E; Akizawa T
    Clin Exp Nephrol; 2014 Feb; 18(1):56-64. PubMed ID: 23740131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous phosphate loading increases fibroblast growth factor 23 in uremic rats.
    Arai-Nunota N; Mizobuchi M; Ogata H; Yamazaki-Nakazawa A; Kumata C; Kondo F; Hosaka N; Koiwa F; Kinugasa E; Shibata T; Akizawa T
    PLoS One; 2014; 9(3):e91096. PubMed ID: 24625659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac effect of vitamin D receptor modulators in uremic rats.
    Mizobuchi M; Ogata H; Yamazaki-Nakazawa A; Hosaka N; Kondo F; Koiwa F; Kinugasa E; Shibata T
    J Steroid Biochem Mol Biol; 2016 Oct; 163():20-7. PubMed ID: 27072785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification.
    Finch JL; Lee DH; Liapis H; Ritter C; Zhang S; Suarez E; Ferder L; Slatopolsky E
    Kidney Int; 2013 Dec; 84(6):1145-53. PubMed ID: 24107846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective Effects of Paricalcitol Alone and in Combination With FGF23 Receptor Inhibition in Chronic Renal Failure: Experimental and Clinical Studies.
    Czaya B; Seeherunvong W; Singh S; Yanucil C; Ruiz P; Quiroz Y; Grabner A; Katsoufis C; Swaminathan S; Abitbol C; Rodriguez-Iturbe B; Faul C; Freundlich M
    Am J Hypertens; 2019 Jan; 32(1):34-44. PubMed ID: 30329020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High phosphate feeding induced arterial medial calcification in uremic rats: roles of Lanthanum carbonate on protecting vasculature.
    Yu C; Chen B; Zhao T; Wang R; Akhtar J; Wang H; Zhang H
    Life Sci; 2013 Oct; 93(17):646-53. PubMed ID: 24012609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure.
    Neves KR; Graciolli FG; dos Reis LM; Pasqualucci CA; Moysés RM; Jorgetti V
    Kidney Int; 2004 Dec; 66(6):2237-44. PubMed ID: 15569312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sevelamer hydrochloride on bone in experimental uremic rats.
    Kuwahara M; Inoshita S; Terada Y; Sasaki S
    Ther Apher Dial; 2009 Feb; 13(1):42-8. PubMed ID: 19379169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.
    De Schutter TM; Behets GJ; Geryl H; Peter ME; Steppan S; Gundlach K; Passlick-Deetjen J; D'Haese PC; Neven E
    Kidney Int; 2013 Jun; 83(6):1109-17. PubMed ID: 23486515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats.
    Ben-Dov IZ; Pappo O; Sklair-Levy M; Galitzer H; Ilan Y; Naveh-Many T; Silver J
    Nephrol Dial Transplant; 2007 Feb; 22(2):362-8. PubMed ID: 17090605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of variations in dietary Pi intake on intestinal Pi transporters (NaPi-IIb, PiT-1, and PiT-2) and phosphate-regulating factors (PTH, FGF-23, and MEPE).
    Aniteli TM; de Siqueira FR; Dos Reis LM; Dominguez WV; de Oliveira EMC; Castelucci P; Moysés RMA; Jorgetti V
    Pflugers Arch; 2018 Apr; 470(4):623-632. PubMed ID: 29372301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease--role of sclerostin?
    Ferreira JC; Ferrari GO; Neves KR; Cavallari RT; Dominguez WV; Dos Reis LM; Graciolli FG; Oliveira EC; Liu S; Sabbagh Y; Jorgetti V; Schiavi S; Moysés RM
    PLoS One; 2013; 8(11):e79721. PubMed ID: 24236156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients.
    Soriano S; Ojeda R; Rodríguez M; Almadén Y; Rodríguez M; Martín-Malo A; Aljama P
    Clin Nephrol; 2013 Jul; 80(1):17-22. PubMed ID: 23391319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure.
    Phan O; Maillard M; Malluche HH; Stehle JC; Funk F; Burnier M
    Biomed Res Int; 2015; 2015():515606. PubMed ID: 26221597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of the phosphate binder, lanthanum carbonate.
    Damment SJ
    Ren Fail; 2011; 33(2):217-24. PubMed ID: 21332344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of phosphonoformic acid and renagel on renal type IIa sodium-dependent phosphate cotransporter mRNA expression in hyperphosphatemia rats.
    Zeng M; Wang X; Wang X; Zhao X
    Ren Fail; 2012; 34(3):358-63. PubMed ID: 22260362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of phosphorus and PTH to the development of cardiac hypertrophy and fibrosis in an experimental model of chronic renal failure.
    Martínez-Arias L; Panizo-García S; Martín-Vírgala J; Martín-Carro B; Fernández-Villabrille S; Avello-Llano N; Miguel-Fernández D; Ruíz Torres MP; Cannata-Andía JB; Carrillo-López N; Naves-Díaz M
    Nefrologia (Engl Ed); 2021; 41(6):640-651. PubMed ID: 36165154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease.
    Carrillo-López N; Panizo S; Alonso-Montes C; Martínez-Arias L; Avello N; Sosa P; Dusso AS; Cannata-Andía JB; Naves-Díaz M
    Nephrol Dial Transplant; 2019 Jun; 34(6):934-941. PubMed ID: 30189026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model.
    Sugiura H; Matsushita A; Futaya M; Teraoka A; Akiyama KI; Usui N; Nagano N; Nitta K; Tsuchiya K
    PLoS One; 2018; 13(3):e0191706. PubMed ID: 29518087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy with lanthanum carbonate and calcium carbonate for hyperphosphatemia decreases serum FGF-23 level independently of calcium and PTH (COLC Study).
    Shigematsu T; Negi S;
    Nephrol Dial Transplant; 2012 Mar; 27(3):1050-4. PubMed ID: 21771755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.